Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 65,860 | 75,597 | 79,221 | 55,284 | 58,838 |
| Receivables | 2,879 | 754 | 1,250 | 1,591 | 6,937 |
| Other current assets | 1,943 | 1,221 | 1,453 | 1,774 | 1,692 |
| TOTAL | $70,682 | $77,572 | $81,924 | $58,649 | $67,467 |
| Non-Current Assets | |||||
| PPE Net | 2,413 | 2,526 | 2,676 | 3,384 | 3,399 |
| Investments And Advances | 2,208 | 2,208 | 2,208 | 3,148 | 3,240 |
| Intangibles | 39,081 | 40,002 | 40,002 | 40,002 | 0 |
| Other Non-Current Assets | 157 | 150 | 150 | 150 | 2,202 |
| TOTAL | $43,859 | $44,886 | $45,036 | $46,684 | $8,841 |
| Total Assets | $114,541 | $122,458 | $126,960 | $105,333 | $76,308 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,512 | 5,904 | 5,961 | 7,837 | 5,640 |
| Other current liabilities | 115 | 115 | 115 | 115 | 115 |
| TOTAL | $6,627 | $6,072 | $6,182 | $8,378 | $8,662 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 53 | 106 | 426 | 838 |
| Other Non-Current Liabilities | 16,614 | 29,498 | 16,815 | 29,665 | 1,078 |
| TOTAL | $28,935 | $29,498 | $29,498 | $29,665 | $1,078 |
| Total Liabilities | $35,562 | $35,570 | $35,680 | $38,043 | $9,740 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,575 | 60,825 | 60,824 | 51,039 | 51,131 |
| Common Shares | 79 | 79 | 78 | 67 | 61 |
| Retained earnings | -466,677 | -458,126 | -447,626 | -435,363 | -424,105 |
| Other shareholders' equity | 67 | 67 | 67 | 7 | -1 |
| TOTAL | $78,979 | $86,888 | $91,280 | $67,290 | $66,568 |
| Total Liabilities And Equity | $114,541 | $122,458 | $126,960 | $105,333 | $76,308 |